Your Advocates Ltd’s CONMED CNMD Stock Holding History

Your Advocates Ltd’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5	Closed	-$679	–	308
2023 Q2	$679	Hold	5	–	–	﹤0.01%	243
2023 Q1	$519	Buy	+5	New	+$484	﹤0.01%	218

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Your Advocates Ltd's CNMD Position: Q3 2023 in Review

Your Advocates Ltd sold out of CONMED (CNMD) in Q3 2023, closing a stake of 5 shares — an estimated $679 sold.

Your Advocates Ltd first reported a position in CNMD in Q1 2023 and held it in 2 quarters. The position peaked at $679 in Q2 2023. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

Your Advocates Ltd reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
Your Advocates Ltd sold 5 CONMED shares in Q3 2023, an estimated $679.
Your Advocates Ltd first reported a position in CONMED in Q1 2023 and held it in 2 quarters.
Your Advocates Ltd's CONMED position peaked at $679 in Q2 2023.
275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Your Advocates Ltd's 13F filing for Q3 2023, filed 2 Nov 2023.